Infinimmune
Founded 2022 · 22 employees on LinkedIn · 3 known investors
Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization. The company serves pharmaceutical and biotech partners developing treatments across 350+ disease targets.
Founders & leadership
Infinimmune was founded in 2022 by Lance Hepler, Katie Pfeiffer, Michael Gibbons, Wyatt McDonnell, and david jaffe.
LH
Lance HeplerinFounder
KP
Katie PfeifferFounder
MG
Michael GibbonsFounder
WM
Wyatt McDonnellFounder
DJ
david jaffeFounder
Investors · 3
Competitors · 6
by search overlap
Inimmune47 shared keywordsInimmune is a clinical-stage biotech company that discovers and develops immunotherapies based on innate immune modulation, including Toll-like receptor agonists, to treat inflammatory conditions such as allergy, cancer, and autoimmune disease. Its lead program, INI-2004, is an intranasal TLR4 agonist in Phase 2 trials for allergic rhinitis, alongside INI-4001, a TLR7/8 agonist in Phase 1 oncology trials, plus pre-clinical vaccine adjuvant work.
Immuneering33 shared keywordsImmuneering develops Deep Cyclic Inhibitors, a class of oncology medicines designed to pulse dosing faster than cancer's adaptive mechanisms to limit resistance and reduce side effects. The company targets more durable tumor control and improved tolerability for cancer patients.
Immunai31 shared keywordsImmunai develops AMICA, a data platform for decoding the immune system to accelerate drug discovery and development. The company serves pharmaceutical and biotech researchers working on inflammatory and oncological therapies.
Bioworld29 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Inmune Bio28 shared keywordsINmune Bio is a clinical-stage biotechnology company developing immunotherapies, including XPro1595, aimed at treating neurodegenerative and psychiatric diseases through a biomarker-directed approach. The company works on translating inflammatory therapies into clinical treatments for neurologic and other diseases.
Immunome26 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
Companies competing with Infinimmune for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Infinimmune do?
- Infinimmune discovers and develops antibody therapeutics using proprietary sequencing technology and AI-powered optimization. The company serves pharmaceutical and biotech partners developing treatments across 350+ disease targets.
- Who founded Infinimmune?
- Infinimmune was founded by Lance Hepler, Katie Pfeiffer, Michael Gibbons, Wyatt McDonnell, david jaffe in 2022.
- Who are Infinimmune's investors?
- Infinimmune's investors include Civilization Ventures Management, Llc, Playground Global, Axial VC.